| As nominal variatea | As continuous variateb |
---|
HR (95% CI) | P value | HR (95% CI) | P value |
---|
Unadjusted | 1.668 (1.330–2.093) |  < 0.001 | 1.194 (1.131–1.260) |  < 0.001 |
Model 1 | 1.554 (1.213–1.992) |  < 0.001 | 1.260 (1.171–1.357) |  < 0.001 |
Model 2 | 1.442 (1.125–1.848) | 0.004 | 1.224 (1.137–1.317) |  < 0.001 |
Model 3 | 1.651 (1.178–2.313) | 0.004 | 1.485 (1.324–1.665) |  < 0.001 |
Model 4 | 1.557 (1.124–2.158) | 0.008 | 1.337 (1.201–1.488) |  < 0.001 |
- Model 1: adjusted for age, sex, BMI
- Model 2: adjusted for variates in Model 1 and previous MI, previous PCI, previous stroke, smoking history, family history of CAD
- Model 3: adjusted for variates in Model 2 and TG, TC, HDL-C, eGFR, hs-CRP, LVEF, ACEI/ARB at discharge
- Model 4: adjusted for variates in Model 3 and LM lesion, bifurcation, multi-vessel lesion, in-stent restenosis, chronic total occlusion lesion, SYNTAX score, LM treatment, LAD treatment, LCX treatment, RCA treatment, complete revascularization, number of DES
- eGDR estimated glucose disposal rate, MACCE major adverse cardio-cerebral events, HR hazard ratio, CI confidence interval
- aThe HR was evaluated regarding the higher median of eGDR as reference
- bThe HR was evaluated by per 1-unit decrease of eGDR